Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trial.
- DOI
- 10.1080/10428194.2017.1421758
- Published
- 2018 Sep
- Container
- Leukemia & lymphoma
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/10428194.2017.1421758,
title = {Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trial.},
author = {Almeida A and Fenaux P and Garcia-Manero G and Goldberg SL and Gröpper S and Jonasova A and Vey N and Castaneda C and Zhong J and Beach CL and Santini V},
year = {2018},
journal = {Leukemia \& lymphoma},
doi = {10.1080/10428194.2017.1421758},
url = {https://doi.org/10.1080/10428194.2017.1421758}
}RIS
TY - JOUR TI - Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trial. AU - Almeida A AU - Fenaux P AU - Garcia-Manero G AU - Goldberg SL AU - Gröpper S AU - Jonasova A AU - Vey N AU - Castaneda C AU - Zhong J AU - Beach CL AU - Santini V PY - 2018 JO - Leukemia & lymphoma DO - 10.1080/10428194.2017.1421758 UR - https://doi.org/10.1080/10428194.2017.1421758 ER -
APA
A, A., P, F., G, G., SL, G., S, G., A, J., N, V., C, C., J, Z., CL, B., & V, S. (2018). Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trial.. Leukemia & lymphoma. https://doi.org/10.1080/10428194.2017.1421758
Source records
- pubmed · retrieved 2026-09-27T09:56:31.573Z